What it is
A community blend combining a GHRH analog (commonly CJC-1295 without DAC / Mod GRF 1-29) with the ghrelin-receptor agonist Ipamorelin, supplied as a co-lyophilized powder.
How it works
The GHRH analog binds pituitary GHRH receptors while Ipamorelin agonizes the ghrelin/GHS receptor; combining the two is thought to produce a larger, more synergistic pulse of growth hormone than either alone.
Where it's used
Used in research/community settings as a combined growth-hormone secretagogue; the two components act on complementary pathways.
Regulatory status
Not FDA-approved; research compounds.
Reconstitution
Supplied as a co-lyophilized powder requiring reconstitution with bacteriostatic water prior to use.
Tracking it
CJC-1295 / Ipamorelin is injectable, so two things matter in a log: when you dosed and where. Rotating sites and writing both down prevents the classic “did I already pin the left side?” problem.
Source
Public reference
Last reviewed 2026-06-11